← Open Payments lookup

SURESH SABBENAHALLI: Open Payments

NPI 1528372505 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,904 in 91 payments from 13 companies in 2025. Trend: 2023 $3,105 · 2024 $1,816 · 2025 $1,904

Food & beverage: $1,895Education: $8
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.21$380
Janssen Pharmaceuticals, Inc11$304
Alkermes, Inc.8$231
ABBVIE INC.12$228
E.R. Squibb & Sons, L.L.C.12$187
Teva Pharmaceuticals USA, Inc.5$105
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$98
Braeburn Inc.5$94
LivaNova USA, Inc.2$87
Otsuka America Pharmaceutical, Inc.4$81

Products named: INGREZZA, VRAYLAR, COBENFY, INVEGA SUSTENNA, LYBALVI, SPRAVATO, AUSTEDO XR, REXULTI.

Industry payments across LA — which companies pay providers there.